These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15623154)

  • 1. The relationship between MRP1 activities and its NBD conformational changes.
    Huang Z; Huang Y
    Sci China C Life Sci; 2004 Oct; 47(5):425-33. PubMed ID: 15623154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains.
    Liu R; Sharom FJ
    Biochemistry; 1996 Sep; 35(36):11865-73. PubMed ID: 8794769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATP binding to the first nucleotide-binding domain of multidrug resistance protein MRP1 increases binding and hydrolysis of ATP and trapping of ADP at the second domain.
    Hou YX; Cui L; Riordan JR; Chang XB
    J Biol Chem; 2002 Feb; 277(7):5110-9. PubMed ID: 11741902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Movement of Cys-697 in myosin ATPase associated with ATP hydrolysis.
    Hiratsuka T
    J Biol Chem; 1992 Jul; 267(21):14941-8. PubMed ID: 1386082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence studies on the nucleotide binding domains of the P-glycoprotein multidrug transporter.
    Liu R; Sharom FJ
    Biochemistry; 1997 Mar; 36(10):2836-43. PubMed ID: 9062112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of carboxylate residues adjacent to the conserved core Walker B motifs in the catalytic cycle of multidrug resistance protein 1 (ABCC1).
    Payen LF; Gao M; Westlake CJ; Cole SP; Deeley RG
    J Biol Chem; 2003 Oct; 278(40):38537-47. PubMed ID: 12882957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attempts to characterize the NBD heterodimer of MRP1: transient complex formation involves Gly771 of the ABC signature sequence but does not enhance the intrinsic ATPase activity.
    Ramaen O; Sizun C; Pamlard O; Jacquet E; Lallemand JY
    Biochem J; 2005 Nov; 391(Pt 3):481-90. PubMed ID: 16014004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the ATPase activity of a novel chimeric fusion protein consisting of the two nucleotide binding domains of MRP1.
    Wan L; Liang X; Huang Y
    Arch Biochem Biophys; 2009 May; 485(2):102-8. PubMed ID: 19285030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FRET analysis indicates that the two ATPase active sites of the P-glycoprotein multidrug transporter are closely associated.
    Qu Q; Sharom FJ
    Biochemistry; 2001 Feb; 40(5):1413-22. PubMed ID: 11170469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replacement of the positively charged Walker A lysine residue with a hydrophobic leucine residue and conformational alterations caused by this mutation in MRP1 impair ATP binding and hydrolysis.
    Buyse F; Hou YX; Vigano C; Zhao Q; Ruysschaert JM; Chang XB
    Biochem J; 2006 Jul; 397(1):121-30. PubMed ID: 16551273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatial proximity of ATP-sensitive tryptophanyl residue(s) and Cys-697 in myosin ATPase.
    Hiratsuka T
    J Biol Chem; 1992 Jul; 267(21):14949-54. PubMed ID: 1386083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP binding, not hydrolysis, at the first nucleotide-binding domain of multidrug resistance-associated protein MRP1 enhances ADP.Vi trapping at the second domain.
    Hou YX; Riordan JR; Chang XB
    J Biol Chem; 2003 Feb; 278(6):3599-605. PubMed ID: 12458196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical characterization and NMR studies of the nucleotide-binding domain 1 of multidrug-resistance-associated protein 1: evidence for interaction between ATP and Trp653.
    Ramaen O; Masscheleyn S; Duffieux F; Pamlard O; Oberkampf M; Lallemand JY; Stoven V; Jacquet E
    Biochem J; 2003 Dec; 376(Pt 3):749-56. PubMed ID: 12954082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional consequences of mutating cysteine residues in the amino terminus of human multidrug resistance-associated protein 1.
    Yang Y; Chen Q; Zhang JT
    J Biol Chem; 2002 Nov; 277(46):44268-77. PubMed ID: 12235150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-decyl-glutathione nonspecifically stimulates the ATPase activity of the nucleotide-binding domains of the human multidrug resistance-associated protein, MRP1 (ABCC1).
    Cool RH; Veenstra MK; van Klompenburg W; Heyne RI; Müller M; de Vries EG; van Veen HW; Konings WN
    Eur J Biochem; 2002 Jul; 269(14):3470-8. PubMed ID: 12135486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug resistance protein MRP1 reconstituted into lipid vesicles: secondary structure and nucleotide-induced tertiary structure changes.
    Manciu L; Chang XB; Riordan JR; Ruysschaert JM
    Biochemistry; 2000 Oct; 39(42):13026-33. PubMed ID: 11041868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-induced conformational changes in the lactose permease of Escherichia coli: evidence for two binding sites.
    Wu J; Frillingos S; Voss J; Kaback HR
    Protein Sci; 1994 Dec; 3(12):2294-301. PubMed ID: 7756985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional and structural consequences of cysteine substitutions in the NH2 proximal region of the human multidrug resistance protein 1 (MRP1/ABCC1).
    Leslie EM; Létourneau IJ; Deeley RG; Cole SP
    Biochemistry; 2003 May; 42(18):5214-24. PubMed ID: 12731862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP binding to the first nucleotide binding domain of multidrug resistance-associated protein plays a regulatory role at low nucleotide concentration, whereas ATP hydrolysis at the second plays a dominant role in ATP-dependent leukotriene C4 transport.
    Yang R; Cui L; Hou YX; Riordan JR; Chang XB
    J Biol Chem; 2003 Aug; 278(33):30764-71. PubMed ID: 12783859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATP-Binding Cassette Transporter Structure Changes Detected by Intramolecular Fluorescence Energy Transfer for High-Throughput Screening.
    Iram SH; Gruber SJ; Raguimova ON; Thomas DD; Robia SL
    Mol Pharmacol; 2015 Jul; 88(1):84-94. PubMed ID: 25924616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.